Literature DB >> 33845064

Automated multi-scale cascade of parallel stirred-tank bioreactors for fast protein expression studies.

Nikolas Von den Eichen1, Lukas Bromig1, Valeryia Sidarava1, Hannah Marienberg1, Dirk Weuster-Botz2.   

Abstract

Automation, parallelization and autonomous operation of standard lab equipment, usually applied for manual bioprocess development, is considered as the key for reduction of bioprocess development time and costs. An automated bioreactor system with 4 stirred-tank bioreactors on a L-scale was combined with a custom-made biomass transfer system to distribute the cell suspensions produced on the L-scale into 48 parallel stirred-tank bioreactors on a mL-scale. Afterwards parallel protein expression studies automated by a liquid handling system with integrated fluorescence reader were performed. Isopropyl β-D-1-thiogalactopyranoside-induced (IPTG) expression of the red fluorescence protein mCherry was studied as an example of using fed-batch processes with recombinant Escherichia coli. In a first automated study, IPTG concentrations were varied in 48 parallel fed-batch processes with E. coli cells produced at a growth rate of 0.1 h-1 on an L-scale and transferred automatically to the mL-scale. The mCherry expression rate increased with increasing inducer concentration until the highest protein expression rate was observed at > 9 μM IPTG. In a second automated study, the growth rate of E. coli was varied between 0.1-0.2 h-1 in parallelly-operated stirred-tank bioreactors on a L-scale. The cells were automatically transferred and distributed into the stirred-tank bioreactors on a mL-scale and the concentration of the inducer IPTG was varied as before in parallel fed-batch processes. An increased growth rate during the production of the recombinant E. coli cells and/or higher cell densities during protein expression resulted in the increased IPTG concentrations necessary to achieve identical expression rates compared to a growth rate of 0.1 h-1 with the exception of very low inducer concentrations and inducer concentrations in excess. The new automated multi-scale cascade of parallel stirred-tank bioreactors should easily be applicable for performing fast optimisation studies with other microbial production systems and will have the potential to reduce bioprocess development time and staff assignment considerably.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Automation; Bioprocess development; Escherichia coli; Protein expression; Stirred-tank bioreactors

Year:  2021        PMID: 33845064     DOI: 10.1016/j.jbiotec.2021.03.021

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  3 in total

1.  Control of parallelized bioreactors I: dynamic scheduling software for efficient bioprocess management in high-throughput systems.

Authors:  Lukas Bromig; Nikolas von den Eichen; Dirk Weuster-Botz
Journal:  Bioprocess Biosyst Eng       Date:  2022-10-18       Impact factor: 3.434

2.  ClearColi as a platform for untagged pneumococcal surface protein A production: cultivation strategy, bioreactor culture, and purification.

Authors:  Valdemir M Cardoso; Sheyla A H Paredes; Gilson Campani; Viviane M Gonçalves; Teresa C Zangirolami
Journal:  Appl Microbiol Biotechnol       Date:  2022-01-13       Impact factor: 4.813

Review 3.  Application of bioreactor technology for cell culture-based viral vaccine production: Present status and future prospects.

Authors:  Zhongbiao Fang; Jingting Lyu; Jianhua Li; Chaonan Li; Yuxuan Zhang; Yikai Guo; Ying Wang; Yanjun Zhang; Keda Chen
Journal:  Front Bioeng Biotechnol       Date:  2022-08-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.